NovaBridge Biosciences (NBP) Receivables - Net (2019 - 2022)
NovaBridge Biosciences (NBP) has disclosed Receivables - Net for 4 consecutive years, with $3.6 million as the latest value for Q4 2022.
- Quarterly Receivables - Net rose 148.44% to $3.6 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2022, up 148.44% year-over-year, with the annual reading at $3.6 million for FY2022, 31.01% down from the prior year.
- Receivables - Net for Q4 2022 was $3.6 million at NovaBridge Biosciences, up from $1.4 million in the prior quarter.
- The five-year high for Receivables - Net was $3.6 million in Q4 2022, with the low at $556172.6 in Q4 2019.
- Average Receivables - Net over 4 years is $1.8 million, with a median of $1.6 million recorded in 2020.
- The sharpest move saw Receivables - Net soared 215.61% in 2020, then dropped 17.88% in 2021.
- Over 4 years, Receivables - Net stood at $556172.6 in 2019, then skyrocketed by 215.61% to $1.8 million in 2020, then decreased by 17.88% to $1.4 million in 2021, then surged by 148.44% to $3.6 million in 2022.
- According to Business Quant data, Receivables - Net over the past three periods came in at $3.6 million, $1.4 million, and $1.8 million for Q4 2022, Q4 2021, and Q4 2020 respectively.